封面
市场调查报告书
商品编码
1618240

智慧医疗设备市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Smart Medical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球智慧医疗设备市场价值 380 亿美元,预估 2024-2032 年复合年增长率为 14.3%。这一令人印象深刻的成长是由智慧型手机相容和无线医疗设备的日益普及以及对健康和健身的日益关注所推动的。有几个因素正在推动市场向前发展,包括医疗保健问题的加剧、慢性病的流行、医疗保健支出的增加以及对穿戴式装置的庞大需求。医院和诊断中心对诊断和治疗即时资料的重视也增强了智慧医疗设备的前景。此外,医疗保健领域持续的技术进步以及改善患者治疗效果的创新解决方案的实施是市场扩张的关键因素。

该市场分为多种产品类型,包括诊断和监测设备、治疗设备和其他相关产品。到 2023 年,光是诊断和监测领域的价值就达到 258 亿美元。治疗设备类别包括携带式製氧机、呼吸器、胰岛素帮浦和助听器。旨在加强患者护理的政府支持措施以及对智慧医疗设备的投资增加正在推动这些领域的成长。

这些设备的通路分为传统零售和电子商务。电子商务正在成为成长最快的领域,预计在预测期内复合年增长率将达到 17.1%。这种增长可归因于透过智慧型手机进行线上购物的趋势不断上升,这为消费者提供了更大的灵活性并获得更广泛的产品。向线上销售管道的转变受到在家购物的便利性、可用产品的多样性以及比较价格和阅读评论的能力的影响。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 380 亿美元
预测值 1,292 亿美元
复合年增长率 14.3%

电子商务平台促进了无缝的购买体验,使患者无需前往实体店或医疗机构即可获得智慧医疗设备。北美智慧医疗设备市场 2023 年收入达 139 亿美元,并预计在未来几年大幅成长。该地区是医疗保健技术创新的领导者,各种因素都促进了智慧医疗设备的进步和广泛采用。关键技术进步,特别是穿戴式科技和感测器精度的进步,正在为更有效、更可靠的医疗解决方案铺平道路。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 糖尿病、气喘和其他疾病的盛行率不断增加
      • 医疗器材产业蓬勃发展
      • 提高网路普及率和巨量资料的采用
      • 即时资料驱动的诊断和治疗方法的重要性日益提高
    • 产业陷阱与挑战
      • 隐私问题
      • 低收入和中等收入国家缺乏适当的基础设施
  • 成长潜力分析
  • 监管环境
  • 报销场景
  • 技术景观
  • 定价分析
  • 未来市场趋势
  • 供应商格局
  • 併购活动
  • 波特的分析
  • PESTEL分析
  • 差距分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品类型,2021 - 2032 年

  • 主要趋势
  • 诊断和监测设备
    • 血糖监测仪
    • 心率监测器
    • 脉搏血氧计
    • 血压计
    • 呼气分析仪
    • 其他诊断和监测设备
  • 治疗设备
    • 便携式製氧机和呼吸机
    • 胰岛素帮浦
    • 助听器
    • 其他治疗设备
  • 其他产品类型

第 6 章:市场估计与预测:依最终用途,2021 - 2032 年

  • 主要趋势
  • 医院
  • 家庭护理设置
  • 其他最终用途

第 7 章:市场估计与预测:按配销通路,2021 - 2032 年

  • 主要趋势
  • 传统实体店
  • 电子商务

第 8 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 9 章:公司简介

  • Abbott
  • Apple
  • Biobeat
  • Boston Scientific Corporation
  • Dexcom
  • F Hoffmann-La Roche
  • Fitbit
  • Medtronic
  • NeuroMetrix
  • Novo Nordisk
  • Omron Corporation
  • SAMSUNG
  • VitalConnect
  • West Pharmaceutical Services
简介目录
Product Code: 1969

The Global Smart Medical Devices Market was worth USD 38 billion in 2023 and is anticipated to grow at 14.3% CAGR throughout 2024-2032. This impressive growth is driven by the rising adoption of smartphone-compatible and wireless medical devices, as well as an increasing focus on health and fitness. Several factors are propelling the market forward, including heightened healthcare concerns, the growing prevalence of chronic diseases, rising healthcare expenditures, and a significant demand for wearable devices. The emphasis on real-time data for diagnostics and treatment in hospitals and diagnostic centers is also enhancing the prospects for smart medical devices. Additionally, ongoing technological advancements in healthcare and the implementation of innovative solutions to improve patient outcomes are key contributors to the market's expansion.

The market is categorized into several product types, including diagnostic and monitoring devices, therapeutic devices, and other related products. The diagnostic and monitoring segment alone was valued at USD 25.8 billion in 2023. This segment encompasses a variety of devices, such as blood glucose monitors, heart rate monitors, pulse oximeters, blood pressure monitors, and breathalyzers. The therapeutic devices category includes portable oxygen concentrators, ventilators, insulin pumps, and hearing aids. Supportive government initiatives aimed at enhancing patient care, along with increased investments in smart medical devices, are driving the growth of these segments.

Distribution channels for these devices are divided into traditional retail and e-commerce. E-commerce is emerging as the fastest-growing segment, with an impressive CAGR of 17.1% projected during the forecast period. This growth can be attributed to the rising trend of online shopping via smartphones, which offers consumers greater flexibility and access to a broader range of products. The shift toward online sales channels is influenced by the convenience of purchasing from home, the variety of products available, and the ability to compare prices and read reviews.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$38 Billion
Forecast Value$129.2 Billion
CAGR14.3%

E-commerce platforms facilitate a seamless purchasing experience, allowing patients to obtain smart medical devices without the need to visit physical stores or healthcare facilities. North American smart medical devices market generated revenues of USD 13.9 billion in 2023 and is poised for significant growth in the coming years. This region stands as a leader in healthcare technology innovation, where various factors are contributing to the advancement and widespread adoption of smart medical devices. Key technological advancements, particularly in wearable technology and sensor accuracy, are paving the way for more effective and reliable medical solutions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of diabetes, asthma and other diseases
      • 3.2.1.2 Booming medical device industry
      • 3.2.1.3 Increasing internet penetration rate and adoption of big data
      • 3.2.1.4 Rising importance of real time data driven approach for diagnostics and treatment
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Privacy concerns
      • 3.2.2.2 Lack of suitable infrastructure in low- and middle-income countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technological landscape
  • 3.7 Pricing analysis
  • 3.8 Future market trends
  • 3.9 Supplier landscape
  • 3.10 M&A activities
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostic and monitoring devices
    • 5.2.1 Blood glucose monitors
    • 5.2.2 Heart rate monitors
    • 5.2.3 Pulse oximeters
    • 5.2.4 Blood pressure monitors
    • 5.2.5 Breathalyzers
    • 5.2.6 Other diagnostic and monitoring devices
  • 5.3 Therapeutic devices
    • 5.3.1 Portable oxygen concentrators and ventilators
    • 5.3.2 Insulin pumps
    • 5.3.3 Hearing aid
    • 5.3.4 Other therapeutic devices
  • 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Homecare settings
  • 6.4 Other End Use

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Brick & mortar
  • 7.3 E-commerce

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Apple
  • 9.3 Biobeat
  • 9.4 Boston Scientific Corporation
  • 9.5 Dexcom
  • 9.6 F Hoffmann-La Roche
  • 9.7 Fitbit
  • 9.8 Medtronic
  • 9.9 NeuroMetrix
  • 9.10 Novo Nordisk
  • 9.11 Omron Corporation
  • 9.12 SAMSUNG
  • 9.13 VitalConnect
  • 9.14 West Pharmaceutical Services